A 6-MONTH, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE BLIND TRIAL OF ZIPRASIDONE PLUS A MOOD STABILIZER IN SUBJECTS WITH BIPOLAR I DISORDER

被引：0
|
作者：
Vieta, E. [1 ]
Bowden, C. [2 ]
Ice, K. [3 ]
Gurtovaya, O. [3 ]
Schwartz, J. [3 ]
Wang, P. [3 ]
机构：
[1] Univ Barcelona, Hosp Clin, Clin Inst Neurosci, IDIBAPS,CIBERSAM, Barcelona, Spain
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA
[3] Pfizer Global Res & Dev, New London, CT USA
来源：
EUROPEAN PSYCHIATRY | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
P01-206
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A 6-Month, randomized, placebo-controlled, double-blind trial of ziprasidone plus a mood stabilizer in subjects with bipolar I disorder
    Bowden, C.
    Vieta, E.
    Ice, K. S.
    Schwartz, J. H.
    Wang, P. P.
    Kremer, C.
    Versavel, M.
    Pappadopulos, E.
    BIPOLAR DISORDERS, 2009, 11 : 23 - 23
  • [2] Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder: A 6-Month, Randomized, Placebo-Controlled, Double-Blind Trial
    Bowden, Charles L.
    Vieta, Eduard
    Ice, Kathleen S.
    Schwartz, Jeffrey H.
    Wang, Paul P.
    Versavel, Mark
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (02) : 130 - 137
  • [3] A 6-month, double-blind trial of ziprasidone plus a mood stabilizer in subjects with bipolar I disorder
    Vieta, E.
    Bowden, C.
    Ice, K. S.
    Schwartz, J. H.
    Wang, P.
    Versavel, M.
    Karayal, O.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S497 - S498
  • [4] Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial
    Woo, Young Sup
    Bahk, Won-Myong
    Chung, Moon Yong
    Kim, Do-Hoon
    Yoon, Bo-Hyun
    Lee, Jong Hun
    Ahn, Yong Min
    Chung, Sang-Keun
    Kim, Jeong-Gee
    Lee, Kwang Heun
    Paik, Ki-Chung
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2011, 26 (08) : 543 - 553
  • [5] Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: A randomized, placebo-controlled trial
    Chengappa, KNR
    Schwarzmann, LK
    Hulihan, JF
    Xiang, J
    Rosenthal, NR
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S235 - S235
  • [6] Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: A randomized, placebo-controlled trial
    Chengappa, K. N. Roy
    Schwarzman, Lesley K.
    Hulihan, Joseph F.
    Xiang, Jim
    Rosenthal, Norman R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (11) : 1698 - 1706
  • [7] A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesity
    Weghuber, D.
    Forslund, A.
    Ahlstrom, H.
    Alderborn, A.
    Bergstrom, K.
    Brunner, S.
    Cadamuro, J.
    Ciba, I
    Dahlbom, M.
    Heu, V
    Hofmann, J.
    Kristinsson, H.
    Kullberg, J.
    Ladinger, A.
    Lagler, F. B.
    Lidstrom, M.
    Manell, H.
    Meirik, M.
    Moerwald, K.
    Roomp, K.
    Schneider, R.
    Vilen, H.
    Widhalm, K.
    Zsoldos, F.
    Bergsten, P.
    PEDIATRIC OBESITY, 2020, 15 (07):
  • [8] Galantamine in AD - A 6-month randomized, placebo-controlled trial with a 6-month extension
    Raskind, MA
    Peskind, ER
    Wessel, T
    Yuan, W
    NEUROLOGY, 2000, 54 (12) : 2261 - 2268
  • [9] A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder
    Brown, E. Sherwood
    Todd, Jackie Peterson
    Hu, Lisa T.
    Schmitz, Joy M.
    Carmody, Thomas J.
    Nakamura, Alyson
    Sunderajan, Prabha
    Rush, A. John
    Adinoff, Bryon
    Bret, Mary Ellen
    Holmes, Traci
    Lo, Alexander
    AMERICAN JOURNAL OF PSYCHIATRY, 2015, 172 (10): : 1014 - 1021
  • [10] Ziprasidone in adjunctive treatment of acute bipolar mania: A randomized, double-blind placebo-controlled trial
    Weisler, RH
    Dunn, J
    English, P
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S344 - S345
12345